DE3523263A1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE3523263A1
DE3523263A1 DE19853523263 DE3523263A DE3523263A1 DE 3523263 A1 DE3523263 A1 DE 3523263A1 DE 19853523263 DE19853523263 DE 19853523263 DE 3523263 A DE3523263 A DE 3523263A DE 3523263 A1 DE3523263 A1 DE 3523263A1
Authority
DE
Germany
Prior art keywords
acid
medicament according
derivative
solution
peroxydiphosphoric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19853523263
Other languages
German (de)
English (en)
Inventor
Abdul Somerset N.J. Gaffar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of DE3523263A1 publication Critical patent/DE3523263A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19853523263 1984-06-27 1985-06-26 Arzneimittel Ceased DE3523263A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62506784A 1984-06-27 1984-06-27
US72654585A 1985-04-24 1985-04-24

Publications (1)

Publication Number Publication Date
DE3523263A1 true DE3523263A1 (de) 1986-01-09

Family

ID=27089811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853523263 Ceased DE3523263A1 (de) 1984-06-27 1985-06-26 Arzneimittel

Country Status (26)

Country Link
JP (1) JPH0623108B2 (nl)
KR (1) KR880002266B1 (nl)
AT (1) AT392002B (nl)
AU (1) AU578104B2 (nl)
BE (1) BE902732A (nl)
CH (1) CH668361A5 (nl)
DE (1) DE3523263A1 (nl)
DK (1) DK168191B1 (nl)
ES (1) ES8801122A1 (nl)
FI (1) FI84697C (nl)
FR (1) FR2566665B1 (nl)
GB (1) GB2161074B (nl)
GR (1) GR851575B (nl)
IE (1) IE58434B1 (nl)
IL (1) IL75518A0 (nl)
IT (1) IT1209961B (nl)
LU (1) LU85976A1 (nl)
MA (1) MA20467A1 (nl)
MC (1) MC1672A1 (nl)
NL (1) NL8501840A (nl)
NZ (1) NZ212301A (nl)
PH (1) PH25613A (nl)
PT (1) PT80707B (nl)
SE (1) SE468501B (nl)
WO (1) WO1986000225A1 (nl)
ZW (1) ZW9585A1 (nl)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
DE3628190A1 (de) * 1985-08-22 1987-02-26 Colgate Palmolive Co Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen
KR100426450B1 (ko) * 2002-03-16 2004-04-13 박래옥 구연산, 알부민 및 아연을 함유한 항암 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
DE3628190A1 (de) * 1985-08-22 1987-02-26 Colgate Palmolive Co Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine

Also Published As

Publication number Publication date
KR860000070A (ko) 1986-01-25
FI852504L (fi) 1985-12-28
IE58434B1 (en) 1993-09-22
DK248085D0 (da) 1985-06-03
IT1209961B (it) 1989-08-30
PT80707B (en) 1986-12-09
IE851597L (en) 1985-12-27
IL75518A0 (en) 1985-10-31
JPS6140217A (ja) 1986-02-26
SE468501B (sv) 1993-02-01
MA20467A1 (fr) 1985-12-31
SE8502876D0 (sv) 1985-06-11
BE902732A (fr) 1985-12-24
AU578104B2 (en) 1988-10-13
FI852504A0 (fi) 1985-06-25
AT392002B (de) 1991-01-10
ES8801122A1 (es) 1988-01-01
FI84697B (fi) 1991-09-30
SE8502876L (sv) 1985-12-28
GB2161074B (en) 1988-04-07
CH668361A5 (de) 1988-12-30
PH25613A (en) 1991-08-08
WO1986000225A1 (en) 1986-01-16
ATA188385A (de) 1990-07-15
KR880002266B1 (ko) 1988-10-21
LU85976A1 (fr) 1986-01-24
JPH0623108B2 (ja) 1994-03-30
FI84697C (fi) 1992-01-10
FR2566665A1 (fr) 1986-01-03
DK168191B1 (da) 1994-02-28
DK248085A (da) 1985-12-28
NZ212301A (en) 1988-04-29
GR851575B (nl) 1985-11-25
IT8548226A0 (it) 1985-06-17
AU4418785A (en) 1986-01-02
GB8515105D0 (en) 1985-07-17
GB2161074A (en) 1986-01-08
NL8501840A (nl) 1986-01-16
FR2566665B1 (fr) 1988-10-21
ES544565A0 (es) 1988-01-01
ZW9585A1 (en) 1985-11-13
PT80707A (en) 1985-07-01
MC1672A1 (fr) 1986-06-03

Similar Documents

Publication Publication Date Title
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
EP1107749B1 (de) Fumarsäurederivate zur behandlung der transplantatabstossung
DE69218557T2 (de) Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3638124C2 (de) Neue pharmazeutische Verwendung von Ebselen
DE69907509T2 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
EP0655249B1 (de) Moenomycin als Arzneimittel zur Behandlung von Magengeschwüren
DE4124409B4 (de) Pharmazeutische Zubereitungen
AT392002B (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
US4975423A (en) Inhibition of tumor development
DE69125204T2 (de) Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln
DE3424997C2 (nl)
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
CH670046A5 (nl)
DE2855306A1 (de) Mittel zur senkung der herzfrequenz
DE2844534C2 (nl)
DE2800110A1 (de) Verfahren zur herstellung neuer antidiarrhoica
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE2753792A1 (de) Antikrebsarzneimittel-zusammensetzung und deren verwendung zur bekaempfung von krebserkrankungen
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
DE3628190A1 (de) Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE1967186C3 (de) Arzneimittel, enthaltend 4,4-Diarylpiperidine
DE3006575A1 (de) Mittel zur behandlung der fettleibigkeit
DE1543792C (de) Monophosphorsäureester von 2,2 Biphenolen sowie Verfahren zu ihrer Her stellung
DE1928518A1 (de) Pharmazeutische Masse

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: STOLBERG-WERNIGERODE, GRAF ZU, U., DIPL.-CHEM. DR.

8110 Request for examination paragraph 44
8131 Rejection